{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:05:33Z","timestamp":1785679533883,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The differential diagnosis of epithelioid mesothelioma from lung adenocarcinoma and squamous cell carcinoma requires the positive and negative immunohistochemical markers of mesothelioma. The IMIG guideline has suggested the use of Calretinin, D2\u201340, WT1, and CK5\/6 as mesothelial markers, TTF-1, Napsin-A, Claudin 4, CEA as lung adenocarcinoma markers p40, p63, CK5\/6, MOC-31 as squamous cell markers. However, use of other immunohistochemical markers is still necessary. We evaluated 65 epithelioid mesotheliomas, 60 adenocarcinomas, and 57 squamous cell carcinomas of the lung for MUC4 expression by immunohistochemistry and compared with the previously known immunohistochemical markers. MUC4 expression was not found in any of 65 cases of epithelioid mesothelioma. In contrast, MUC4 expression was observed in 50\/60(83.3%) cases of lung adenocarcinoma and 50\/56(89.3%) cases of lung squamous cell carcinoma. The negative MUC4 expression showed 100% sensitivity, 86.2% specificity and accuracy rate of 91.2% to differentiate epithelioid mesothelioma from lung carcinoma. The sensitivity, specificity, and accuracy of MUC4 are comparable to that of previously known markers of lung adenocarcinoma and squamous cell carcinoma, namely CEA, Claudin 4 and better than that of MOC-31. In conclusion, MUC4 immunohistochemistry is useful for differentiation of epithelioid mesothelioma from lung carcinoma, either adenocarcinoma or squamous cell carcinoma.<\/jats:p>","DOI":"10.1038\/s41598-017-18545-x","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T10:18:42Z","timestamp":1514974722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung"],"prefix":"10.1038","volume":"8","author":[{"given":"Amany Sayed","family":"Mawas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-2109","authenticated-orcid":false,"given":"Vishwa Jeet","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"18545_CR1","doi-asserted-by":"publisher","unstructured":"Delgermaa, V. et al. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89, 716\u2013724, 724A-724C, https:\/\/doi.org\/10.2471\/BLT.11.086678 (2011).","DOI":"10.2471\/BLT.11.086678"},{"key":"18545_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos, R. L. & Gibbs, A. R. \u2018Pseudomesotheliomatous\u2019 carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 43, 444\u2013452 (2003).","journal-title":"Histopathology"},{"key":"18545_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle, F., Churg, A., Roggli, V. & Travis, W. D., World Health Organization Committee for Tumors of the, P. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. J Thorac Oncol 11, 142\u2013154, https:\/\/doi.org\/10.1016\/j.jtho.2015.11.005 (2016).","journal-title":"J Thorac Oncol"},{"key":"18545_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain, A. N. et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137, 647\u2013667, https:\/\/doi.org\/10.5858\/arpa.2012-0214-OA (2013).","journal-title":"Arch Pathol Lab Med"},{"key":"18545_CR5","doi-asserted-by":"publisher","unstructured":"Kuraoka, M. et al. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for its Differentiation From Pulmonary Adenocarcinoma. Am J Surg Pathol, https:\/\/doi.org\/10.1097\/PAS.0000000000000852 (2017).","DOI":"10.1097\/PAS.0000000000000852"},{"key":"18545_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D. et al. The2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 10, 1243\u20131260, https:\/\/doi.org\/10.1097\/JTO.0000000000000630 (2015).","journal-title":"J Thorac Oncol"},{"key":"18545_CR7","first-page":"D95","volume":"5","author":"KL Carraway","year":"2000","unstructured":"Carraway, K. L. et al. Multiple facets of sialomucin complex\/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). Front Biosci 5, D95\u2013D107 (2000).","journal-title":"Front Biosci"},{"key":"18545_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/oxfordjournals.jbchem.a022746","volume":"128","author":"A Choudhury","year":"2000","unstructured":"Choudhury, A. et al. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem 128, 233\u2013243 (2000).","journal-title":"J Biochem"},{"key":"18545_CR9","first-page":"5546","volume":"58","author":"RL Giuntoli II","year":"1998","unstructured":"Giuntoli, R. L. II, Rodriguez, G. C., Whitaker, R. S., Dodge, R. & Voynow, J. A. Mucin gene expression in ovarian cancers. Cancer Res 58, 5546\u20135550 (1998).","journal-title":"Cancer Res"},{"key":"18545_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hed.10387","volume":"26","author":"DT Weed","year":"2004","unstructured":"Weed, D. T. et al. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head Neck 26, 353\u2013364, https:\/\/doi.org\/10.1002\/hed.10387 (2004).","journal-title":"Head Neck"},{"key":"18545_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1165\/ajrcmb.24.1.4294","volume":"24","author":"A Lopez-Ferrer","year":"2001","unstructured":"Lopez-Ferrer, A. et al. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 24, 22\u201329, https:\/\/doi.org\/10.1165\/ajrcmb.24.1.4294 (2001).","journal-title":"Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol"},{"key":"18545_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/gut.47.3.349","volume":"47","author":"A Lopez-Ferrer","year":"2000","unstructured":"Lopez-Ferrer, A. et al. Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 47, 349\u2013356 (2000).","journal-title":"Gut"},{"key":"18545_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1023\/A:1011327708973","volume":"6","author":"KL Carraway","year":"2001","unstructured":"Carraway, K. L. et al. Muc4\/sialomucin complex in the mammary gland and breast cancer. J Mammary Gland Biol Neoplasia 6, 323\u2013337 (2001).","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"18545_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1043\/1543-2165","volume":"131","author":"KY Kwon","year":"2007","unstructured":"Kwon, K. Y. et al. MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Arch Pathol Lab Med 131, 593\u2013598, https:\/\/doi.org\/10.1043\/1543-2165 (2007).","journal-title":"Arch Pathol Lab Med"},{"key":"18545_CR15","doi-asserted-by":"publisher","unstructured":"Rokutan-Kurata, M. et al. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. Clin Lung Cancer, https:\/\/doi.org\/10.1016\/j.cllc.2016.11.013 (2016).","DOI":"10.1016\/j.cllc.2016.11.013"},{"key":"18545_CR16","first-page":"10274","volume":"8","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis. Int J Clin Exp Med 8, 10274\u201310283 (2015).","journal-title":"Int J Clin Exp Med"},{"key":"18545_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000227547","volume":"53","author":"CJ Yu","year":"1996","unstructured":"Yu, C. J. et al. Mucin mRNA expression in lung adenocarcinoma cell lines and tissues. Oncology 53, 118\u2013126 (1996).","journal-title":"Oncology"},{"issue":"Pt 2","key":"18545_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/bj3380325","volume":"338","author":"N Moniaux","year":"1999","unstructured":"Moniaux, N. et al. Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338(Pt 2), 325\u2013333 (1999).","journal-title":"Biochem J"},{"key":"18545_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005537-200408001-00001","volume":"114","author":"DT Weed","year":"2004","unstructured":"Weed, D. T. et al. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes. Laryngoscope 114, 1\u201332, https:\/\/doi.org\/10.1097\/00005537-200408001-00001 (2004).","journal-title":"Laryngoscope"},{"key":"18545_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/modpathol.2016.181","volume":"30","author":"VJ Amatya","year":"2017","unstructured":"Amatya, V. J. et al. MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30, 672\u2013681, https:\/\/doi.org\/10.1038\/modpathol.2016.181 (2017).","journal-title":"Mod Pathol"},{"key":"18545_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/modpathol.3800027","volume":"17","author":"K Llinares","year":"2004","unstructured":"Llinares, K. et al. Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Mod Pathol 17, 150\u2013157, https:\/\/doi.org\/10.1038\/modpathol.3800027 (2004).","journal-title":"Mod Pathol"},{"key":"18545_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","volume":"44","author":"NG Ordonez","year":"2013","unstructured":"Ordonez, N. G. Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update. Hum Pathol 44, 1\u201319, https:\/\/doi.org\/10.1016\/j.humpath.2012.05.014 (2013).","journal-title":"Hum Pathol"},{"key":"18545_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","volume":"139","author":"NG Ordonez","year":"2013","unstructured":"Ordonez, N. G. Value of claudin-4 immunostaining in the diagnosis of mesothelioma. Am J Clin Pathol 139, 611\u2013619, https:\/\/doi.org\/10.1309\/AJCP0B3YJBXWXJII (2013).","journal-title":"Am J Clin Pathol"},{"key":"18545_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/modpathol.3800544","volume":"19","author":"NG Ordonez","year":"2006","unstructured":"Ordonez, N. G. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Mod Pathol 19, 417\u2013428, https:\/\/doi.org\/10.1038\/modpathol.3800544 (2006).","journal-title":"Mod Pathol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18545-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:40:41Z","timestamp":1671846041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18545-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18545"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18545-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]},"assertion":[{"value":"8 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"134"}}